Safety surveillance of influenza A(H1N1)v monovalent vaccines during the 2009-2010 mass vaccination campaign in France

被引：8

作者：

Caillet, Celine ^{[2
]}

Durrieu, Genevieve ^{[1
,2
]}

Jacquet, Alexis

Faucher, Angeline ^{[2
,3
]}

Ouaret, Scheherazade ^{[3
]}

Perrault-Pochat, Marie-Christine ^{[4
]}

Kreft-Jais, Carmen ^{[3
]}

Castot, Anne ^{[3
]}

Montastruc, Jean-Louis ^{[2
]}

机构：

[1] Fac Med, Lab Pharmacol Med & Clin, F-31000 Toulouse, France

[2] Univ Toulouse, Fac Med, Ctr Hosp Univ,Ctr Midi Pyrenees PharmacoVigilance, Lab Pharmacol Med & Clin,INSERM 1027,Unite Pharma, F-31000 Toulouse, France

[3] AFSSAPS, Paris, France

[4] Assoc Francaise Ctr Regionaux PharmacoVigilance, Paris, France

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2011年 / 67卷 / 06期

关键词：

ADVERSE DRUG-REACTIONS; DIAGNOSTIC-CRITERIA;

D O I：

10.1007/s00228-010-0961-8

中图分类号：

R9 [药学];

学科分类号：

100702 [药剂学];

摘要：

引用

页码：649 / 651

页数：3

共 8 条

[1]

ASSESSMENT OF CURRENT DIAGNOSTIC-CRITERIA FOR GUILLAIN-BARRE-SYNDROME [J].

ASBURY, AK ;

CORNBLATH, DR .

ANNALS OF NEUROLOGY, 1990, 27 :S21-S24

[2]

Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines [J].

Black, Steven ;

Eskola, Juhani ;

Siegrist, Claire-Anne ;

Halsey, Neal ;

MacDonald, Noni ;

Law, Barbara ;

Miller, Elizabeth ;

Andrews, Nick ;

Stowe, Julia ;

Salmon, Daniel ;

Vannice, Kirsten ;

Izurieta, Hector S. ;

Akhtar, Aysha ;

Gold, Mike ;

Oselka, Gabriel ;

Zuber, Patrick ;

Pfeifer, Dina ;

Vellozzi, Claudia .

LANCET, 2009, 374 (9707) :2115-2122

[3]

The Medical Dictionary for Regulatory Activities (MedDRA) [J].

Brown, EG ;

Wood, L ;

Wood, S .

DRUG SAFETY, 1999, 20 (02) :109-117

[4]

Adverse drug reactions: definitions, diagnosis, and management [J].

Edwards, IR ;

Aronson, JK .

LANCET, 2000, 356 (9237) :1255-1259

[5]

*EMA, 2009, CHMP REC PHARM PLAN

[6]

Under-reporting of adverse drug reactions - A systematic review [J].

Hazell, Lorna ;

Shakir, Saad A. W. .

DRUG SAFETY, 2006, 29 (05) :385-396

[7]

Moore N, 2007, PHARMACOVIGILANCE, P217

[8]

Diagnostic criteria for multiple sclerosis: 2005 Revisions to the "McDonald Criteria" [J].

Polman, CH ;

Reingold, SC ;

Edan, G ;

Filippi, M ;

Hartung, HP ;

Kappos, L ;

Lublin, FD ;

Metz, LM ;

McFarland, HF ;

O'Connor, PW ;

Sandberg-Wollheim, M ;

Thompson, AJ ;

Weinshenker, BG ;

Wolinsky, JS .

ANNALS OF NEUROLOGY, 2005, 58 (06) :840-846

← 1 →